China has increased prices of key starting materials (KSMs), which are used for making medicines, by 10-20%, leaving those of basic raw materials — or active pharmaceutical ingredients (APIs) — largely unchanged. Both KSMs and APIs are imported in India for making life-saving antibiotics, steroids and other medicines.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2RPndGG
